Isolation in Brazil of nosocomial Staphylococcus aureus With reduced susceptibility to vancomycin

Infection Control and Hospital Epidemiology

Volumn 22, Issue 7, 2001, Pages 443-448

  Oliveira, Geraldo A ^a   Dell’aquila, Adriana M ^b   Masiero, Rita L ^b   Levy, Carlos E ^a   Gomes, Marcia S ^b   Cui, Longzhu ^c   Hiramatsu, Keiichi ^c   Mamizuka, Elsa M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hypertension Unit General Hospital   (Brazil)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BRAZIL; CHILD; CLINICAL ARTICLE; FEMALE; HOSPITAL; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFANT; INFECTION CONTROL; MALE; PRESCHOOL CHILD; PULSED FIELD GEL ELECTROPHORESIS; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS;

EID: 0034826492     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501932     Document Type: Article

References (34)

1. Vancomycin resistance in staphylococci
2. Emergence of vancomycin resistance in Staphylococcus aureus
3. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
4. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
5. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
6. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides
7. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia
8. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection
9. Vancomycin-resistant Staphylococcus aureus occurs in South Africa
10. Vancomycin-intermediate Staphylococcus aureus in Korea
11. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50
12. Characterization of glycopeptide-resistant enterococci from U.S. hospitals
13. Detection of vancomycin-resistant enterococci in fecal samples by PCR
14. Molecular epidemiology of nosocomial infection: Analysis of chromosomal restriction fragment patterns by pulsed-field gel electrophoresis
15. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
16. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50
17. Geographic spread of epidemic multiresistant Staphylococcus aureus clone in Brazil
18. Evaluation of interhospital spread of methicillin-resistant Staphylococcus aureus in São Paulo, Brazil, using pulsed-field gel electrophoresis of chromosomal DNA
19. Implications of vancomycin-resistant Staphylococcus aureus
20. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin
21. Simplified dosing and monitoring of vancomycin for the burn care clinician
22. Nosocomial burn wound infections
23. Analysis of vancomycin populations susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus
24. Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates
25. Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds
26. Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus
27. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan
28. In vitro activities of co-amoxiclav at concentrations achieved in human serum against the resistant subpopulation of heteroresistant Staphylococcus aureus: A controlled study with vancomycin
29. Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin
30. An overview of nosocomial infection control in Brazil
31. Staphylococcus aureus with intermediate resistance to vancomycin: Mechanisms of resistance, laboratory detection and perspectives of appearance in Brazil
32. Glycopeptide-intermediate Staphylococcus aureus: Evaluation of a novel screening method and results of a survey of selected U.S. hospitals